Morphose: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Morphose
Largest movements
- Stocks and contracts -€14,219
no longer reported in 2025 (was €14,219)
- Receivables within one year +€14,195
up €14,195 (+124.6%), from €11,395 to €25,590
- Current investments -€1,207
down €1,207 (-51.5%), from €2,344 to €1,136
- Trade debts -€15,418
down €15,418 (-78.9%), from €19,535 to €4,117
- Debts after one year +€7,836
up €7,836 (+12.2%), from €64,190 to €72,025
of which Financial debts: +€8,836
- Provisions +€5,929
new in 2025: €5,929
- Profit (loss) carried forward +€422
up €422 (+0.7%), from -€58,767 to -€58,345
- Financial income +€8,357
new in 2025: €8,357
- Provisions +€5,929
new in 2025: €5,929
- Financial charges -€1,468
down €1,468 (-95.4%), from €1,538 to €70
- Other operating charges +€935
up €935 (+103.8%), from €900 to €1,835
- Gross operating margin -€380
down €380, from €279 to -€101
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €27,958 | €26,726 | -€1,232 | -4.4% |
| Current assets | 29/58 | €27,958 | €26,726 | -€1,232 | -4.4% |
| Stocks and contracts in progress | 3 | €14,219 | - | -€14,219 | |
| Stocks | 30/36 | €14,219 | - | -€14,219 | |
| Amounts receivable within one year | 40/41 | €11,395 | €25,590 | +€14,195 | +124.6% |
| Other amounts receivable | 41 | €11,395 | €25,590 | +€14,195 | +124.6% |
| Current investments | 50/53 | €2,344 | €1,136 | -€1,207 | -51.5% |
| Total equity and liabilities | 10/49 | €27,958 | €26,726 | -€1,232 | -4.4% |
| Equity | 10/15 | -€55,767 | -€55,345 | +€422 | +0.8% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€58,767 | -€58,345 | +€422 | +0.7% |
| Provisions and deferred taxes | 16 | - | €5,929 | +€5,929 | |
| Provisions for liabilities and charges | 160/5 | - | €5,929 | +€5,929 | |
| Other liabilities and charges | 164/5 | - | €5,929 | +€5,929 | |
| Amounts payable | 17/49 | €83,725 | €76,142 | -€7,583 | -9.1% |
| Amounts payable after more than one year | 17 | €64,190 | €72,025 | +€7,836 | +12.2% |
| Financial debts | 170/4 | €63,190 | €72,025 | +€8,836 | +14.0% |
| Other amounts payable | 178/9 | €1,000 | - | -€1,000 | |
| Amounts payable within one year | 42/48 | €19,535 | €4,117 | -€15,418 | -78.9% |
| Trade debts | 44 | €19,535 | €4,117 | -€15,418 | -78.9% |
| Suppliers | 440/4 | €19,535 | €4,117 | -€15,418 | -78.9% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | - | €5,929 | +€5,929 | |
| Other operating charges | 640/8 | €900 | €1,835 | +€935 | +103.8% |
| Gross operating margin | 9900 | €279 | -€101 | -€380 | |
| Operating profit (loss) | 9901 | -€621 | -€7,865 | -€7,244 | -1166.2% |
| Financial income | 75/76B | - | €8,357 | +€8,357 | |
| Recurring financial income | 75 | - | €8,357 | +€8,357 | |
| Financial charges | 65/66B | €1,538 | €70 | -€1,468 | -95.4% |
| Recurring financial charges | 65 | €1,538 | €70 | -€1,468 | -95.4% |
| Profit (loss) for the period before taxes | 9903 | -€2,159 | €422 | +€2,581 | |
| Profit (loss) for the period | 9904 | -€2,159 | €422 | +€2,581 | |
| Profit (loss) for the period to be appropriated | 9905 | -€2,159 | €422 | +€2,581 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.